Clinical Trial Update: Dalfampridine for Imbalance in Multiple Sclerosis [Phase 2]

View source ↗

Summary

Phase 2 trial results of dalfampridine (Ampyra) for imbalance in people with multiple sclerosis were posted in 2014. The study evaluated outcomes related to imb…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Sclerosis

Drugs mentioned

• Ampyra (4-aminopyridine)

Snippet

Sponsor: Oregon Health and Science University | Conditions: Multiple Sclerosis, Fatigue | Phase 2 | Status: COMPLETED | Results posted: 2014-06-16